Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer

Condition:   Inflammatory Breast Cancer Interventions:   Drug: Pembrolizumab Injection;   Drug: neoadjuvant (F)EC-paclitaxel chemotherapy Sponsors:   Institut Paoli-Calmettes;   MSD France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials